Trial Profile
Effect of deferasirox on cardiac iron overload in beta thalassemia major patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Iron overload
- Focus Therapeutic Use
- 19 Dec 2015 New trial record